Aequs Limited is set to launch its IPO for public subscription on December 3, 2025, and will remain open until December 5, 2025.
The Aequs IPO price range is set between ₹118.00 and ₹124.00 per equity share. The minimum lot size for one IPO application is 120 shares.
Through this IPO, the company will list on both the BSE and NSE exchanges as of December 10, 2025. The final allotment results for the Aequs IPO will be announced by December 8, 2025.
The Aequs IPO size is a ₹921.81 crores book-building issue comprising 5.40 crore shares (raising ₹670.00 crores) as a fresh issue and ₹251.81 crores through the Offer-for-Sale (OFS) of 2.03 crore shares.
Founded in 2006, Aequs Limited is an integrated precision manufacturing company specialising in high-complexity components for the global aerospace industry.
With end-to-end capabilities across forging, machining, surface treatment, assembly, and testing, the company operates as one of India's largest aerospace manufacturing clusters at its SEZ (Special Economic Zone) in Belagavi, Karnataka.
Backed by a fully captive ecosystem and advanced manufacturing technologies, Aequs delivers structural parts, landing-gear components, engine parts, and precision assemblies to leading global OEMs and Tier-1 suppliers.
Apart from this, the company also earns nearly 90% of its revenue from the aerospace segment and supplies to major customers across the US, Europe, and Asia. Their integrated cluster model enables faster turnaround, better quality control, and competitive cost efficiencies.
Aequs continues to expand its capabilities across aerospace, consumer products, and industrial manufacturing, supported by large-scale infrastructure and a growing global customer base.
The following are the upcoming IPO details of Aequs Limited.
| Particulars | Details |
|---|---|
| IPO Size | Book Build issue of ₹921.81 crores |
| Offer Type | Fresh issue of ₹670 crores + Offer for Sale (OFS) of ₹251.81 crores |
| Total Number of Equity Shares | 7,43,39,651 shares (estimated) |
| Price Band | ₹118 to ₹124 per share |
| Issue Dates | Opens: December 3, 2025 Closes: December 5, 2025 |
| Minimum Bid Lot | 1 lot of 120 shares |
| Allotment Date | December 8, 2025 |
| Listing Date | December 10, 2025 |
| Face Value | ₹10 per share |
| Use of Proceeds (est amounts) |
|
| Lead Managers (BRLMs) |
|
| Registrar | KFin Technologies Limited |
| Listing Exchanges | National Stock Exchange of India (NSE) & Bombay Stock Exchange (BSE) |
Before applying for the IPO, investors should know which category they qualify for. For instance, the Aequs IPO retail quota is up to ₹2 lakhs. Likewise, for other categories, you can look at the table.
| Investor Category | % Shares Offered | Bidding allowed |
|---|---|---|
| Only RII | Up to ₹2 Lakhs | Yes |
| Only sNII | ₹2 Lakhs to ₹10 Lakhs | No |
| Only bNII | ₹10 Lakhs to NII Reservation Portion | No |
| Only employee | Up to ₹5 Lakhs | Yes |
| Employee + RII/NII | Applying as;
| Yes |
For each category, there is a specific lot size and shares available within it.
| Application | Lots | No. of Shares within the lots | Amount in INR (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 120 | ₹14,880 |
| Retail (Max) | 13 | 1,560 | ₹1,93,440 |
| S-HNI (Min) | 14 | 1,680 | ₹2,08,320 |
| S-HNI (Max) | 67 | 8,040 | ₹9,96,960 |
| B-HNI (Min) | 68 | 8,160 | ₹10,11,840 |
(Note: sNII refers to "Small Non-institutional investors" and bNII refers to "Big Non-institutional Investors." Likewise, RII is for retail institutional investors.)
The Net proceeds from the Aequs IPO shall be utilized for the following purposes:
| Objective | Amount (₹ in crores) |
|---|---|
| Repayment or prepayment of the penalties or borrowings. | ₹433.17 crores |
| Capital expenditure on the acquisition of machinery and equipment. | ₹64.002 crores |
| Inorganic growth & strategic investments | To be finalised (overall cap up to 35% of gross proceeds) |
| General corporate purposes | To be finalised (shall not exceed 25% of gross proceeds) |
The shareholding of Aequs Limited is divided among: Aequs Manufacturing Investments Private Limited, Melligeri Private Family Foundation, and Aravind Melligeri.
| Promoter | Shareholding (Pre-Issue) |
|---|---|
| Aequs Manufacturing Investments Private Limited | 47.16% |
| Melligeri Private Family Foundation | 16.50% |
| Aravind Melligeri | 0.16% |
| Total Promoter's Shareholding | 64.48% |
Here's the table showing Aequs Limited's financial performance from FY 2023 to FY 2025 and as of Sep 30, 2025.
| Period Ended | As of Sep 30, 2025 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 |
|---|---|---|---|---|
| Assets | 2,134.35 | 1,859.84 | 1,863.50 | 1,822.98 |
| Total Income | 565.55 | 959.21 | 475.51 | 988.30 |
| Profit After Tax | -16.98 | -102.35 | -71.70 | -14.24 |
| EBITDA | 84.11 | 107.97 | 57.82 | 145.51 |
| NET Worth | 796.04 | 707.53 | 731.65 | 807.17 |
| Reserves and Surplus | 200.43 | 135.09 | -90.83 | -15.31 |
| Total Borrowing | 533.51 | 437.06 | 384.79 | 291.88 |
Based on the consolidated financial statements of Aequs Limited, for FY 2024-25 and as of Sep 30, 2025, the following financial metrics can be considered.
| KPI | As of Sep 30, 2025 | Values (as of FY 2024-25) |
|---|---|---|
| Return on Equity (ROE) | (2.07) | (14.30) |
| Net Asset Value (NAV) | 13.60 | 12.47 |
| Earnings Per Share (EPS) | (0.3) | (1.80) |
| Return on Capital Employed (ROCE) | 1.81 | 0.87 |
| EBITDA Margin (%) | (23.91) | (28.68) |
| PAT Margin (%) | (3.16) | (11.07) |
| Debt to Equity Ratio | 0.98 | 0.99 |
(Note: The () indicates the losses incurred by the business in the respective period.)
Here's a brief business overview of the Aequs Limited IPO that explains the strengths and weaknesses to help you make informed decisions.
Fully Integrated Aerospace Manufacturing
Aequs is the only precision component manufacturer in India operating within a single SEZ, offering end-to-end capabilities, including machining, forging, molding, surface treatment, and assembly.
Unique Engineering-Led Ecosystem
Its vertically integrated, co-located facilities improve supply-chain efficiency, reduce turnaround time, and enable seamless manufacturing workflows.
Global Manufacturing Presence
Aequs operates across India, the U.S., and France, offering strategic proximity to global OEMs and serving customers across three continents.
Large, Diversified Product Portfolio
With 5,000+ aerospace products, CNC machining, molding, and multi-axis capabilities, Aequs supports a wide range of manufacturing and assembly programs.
Scaled Production Capacity
The company has 2.92 million machining/molding hours, 200+ CNC machines, 161 molding machines, and 2.22 million sq. ft. of manufacturing space.
Strong Workforce & Engineering Talent
Aequs employs 4,538+ people, including 855 engineers, backed by continuous training to enhance precision manufacturing expertise.
Proven OEM Relationships
Long-standing ties with global aerospace customers, built on a deep understanding of complex component requirements and fast turnaround capabilities.
High Local Value Addition
For select products, Aequs delivers 100% in-country value addition, strengthening India’s aerospace supply chain.
1. Deepen Business With Existing Aerospace Customers
In the upcoming period, the company plans to boost its existing customer base by;
2. Expand and Diversify Customer Base in Aerospace
3. Grow the Consumer Products Portfolio
Almost 90% of Aequs' revenue comes from the aerospace segment. If global aircraft demand slows, their business takes a direct hit.
A few big clients contribute a large share of revenue. If even one reduces orders or delays payments, it can impact cash flow.
Most orders are requirement-based, not guaranteed. This makes quarterly revenues unpredictable.
Aequs needs heavy investments in machinery and infrastructure. If utilisation drops, profits fall sharply.
The company has seen negative operating cash flows and rising borrowings. This increases financial pressure.
Any delay in sourcing metals or disruption in logistics can stall production and impact deliveries.
Working with global aerospace OEMs means strict certifications. Any compliance slip can lead to loss of contracts.
All plants are in Karnataka. A regional disruption, like floods, strikes, or policy changes, can shut down operations.
Aequs has been repeatedly reporting losses – ₹169.77 million (September 2025), ₹1,023.46 million (FY25), ₹142.44 million (FY24), and ₹1,094.95 million (FY23). It has also written down the value of some subsidiaries. If this trend continues, it could put more pressure on the company's finances.
Global slowdowns, geopolitical tensions, currency fluctuations, or supply-chain shocks can affect aerospace demand and customer orders.
Here's how you can check your IPO allotment status for Aequs Limited.
The Aequs IPO registrar, as per RHP, is KFin Technologies Limited.
Phone: 04067162222, 04079611000
Email: aequs.ipo@kfintech.com
The lead managers handling the IPO process of Aequs Ltd are;
All IPO details, including issue size, price band, and timelines, are sourced from the company’s Red Herring Prospectus (RHP) and publicly available data at the time of writing. This blog is meant only for awareness and educational purposes - it’s not investment advice. Please go through the RHP carefully available on the SEBI website. Henceforth, investors are requested to do their own research and due diligence before investing in any IPO. The author and platform do not guarantee the accuracy or completeness of the information and shall not be held responsible for any financial losses arising from investment decisions based on this content.
Express Zone A Wing 10th Floor, Western Express Highway, Goregaon east, Mumbai - 400063
11th Floor, Times Tower, Kamala Mills, Senapati Bapat Marg, Lower Parel, Mumbai - 400 013
Anand Rathi Share and Stock Brokers Ltd.
SEBI Registration No.: INZ000170832 (BSE-949 | NSE-06769 | MSEI-1014 | MCX-56185 | NCDEX-1252), CDSL & NSDL: IN-DP-437-2019. *Research Analyst - INH000000834. PMS: INP000000282 is Registered under "Anand Rathi Advisors Limited" | MBD-INM000010478 is Registered under "Anand Rathi Advisors Limited"| NBFC is Registered under "Anand Rathi Global Finance Limited" Regn. No.: B-13.01682 | Insurance is Registered under "Anand Rathi Insurance Brokers Ltd." License No. 175. Insurance Corporate Agent: CA1048 (This registration shall be valid from 04-Jun-2025 to 03-Jun-2028).
Anand Rathi International Ventures (IFSC) Private Limited.
SEBI Registration No.: INZ000292939 (INDIA INX Member Code: TM - 5064 | NSE IX Member Code: TM -10048, IIBX Member Code: TM – 2011), IIDI DP ID 350071 AND Registration No.: IFSCA/DP/2022-23/007, IFSCA/CMI/Distributor/2023-24/0002. CIN No.: U65999GJ2016PTC094915. For any complaints email at Ifscgrievance@rathi.com. Regulator: International Financial Services Centres Authority (IFSCA)- https://www.ifsca.gov.in/
Disclaimer:
Equity: Investment in securities market are subject to market risks, read all the related documents carefully before investing.
The securities are quoted as an example and not as a recommendation.
Mutual Funds: Mutual Fund investments are subject to market risks, read all scheme related documents carefully before Investing. AMFI-Registered Mutual Fund Distributor: ARN-4478 (Initial Registration 4th Feb, 2003 & Valid From 2nd April, 2025 - 1st April, 2028) : Anand Rathi Share and Stock Brokers Ltd. | ARN-111569: Anand Rathi Wealth Limited | ARN-100284: AR Digital Wealth Private Limited.
IPO: Opening of account will not guarantee allotment of shares in IPO. Investors are requested to do their own due diligence before investing in any IPO.
*Third Party products: All third-party products like PMS, Mutual Funds, Fixed Income Products, IBS, Bonds, AIFs are not Exchange traded product and "ARSSBL" is just acting as distributor. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism.
MTF: MTF is subject to the provisions of SEBI Cir. CIR/MRD/DP/54/2017 dt June 13, 2017 & terms and conditions mentioned in rights and obligations statement issued by the ARSSBL
Investment Baskets: Baskets are not Exchange traded product, all disputes with respect to this activity, would not have access to Exchange investor redressal forum or Arbitration mechanism.
Research Analyst: The views expressed in this website accurately reflect the personal views of the analyst(s) about the subject securities or issuers and no part of the compensation of the research analyst(s) was, is, or will be directly or indirectly related to the specific recommendations or views expressed by the research analyst(s). The advertisment are bound by stringent internal regulations and also legal and statutory requirements of the Securities and Exchange Board of India (hereinafter "SEBI").
Certification: Registration granted by SEBI and certification from NISM is in no way a guarantee of performance of the intermediary or provides any assurance of returns to investors.
*Award Winning Research: Anand Rathi Share and Stock Brokers Limited (Research Analyst) was awarded as "Best Equity Advisor" at World BFSI Congress & Awards 2022
*Client Data: Client data shown on this website is as on 31st March 2025
Trading View: Anand Rathi has partnered with TradingView for its charting technology. A global platform offering heatmaps, STOCK SCREENERS and market data.
By submitting this form, I hereby provide my explicit consent to be contacted by Anand Rathi Group and its associate companies via phone call, SMS, email, or WhatsApp for information related to products and services, even if I am registered on DND.
Attention Investors: